SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024280
Filing Date
2020-05-11
Accepted
2020-05-11 16:40:14
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-10q_20200331.htm   iXBRL 10-Q 2066849
2 EX-10.1 mrus-ex101_52.htm EX-10.1 29746
3 EX-10.2 mrus-ex102_51.htm EX-10.2 100560
4 EX-31.1 mrus-ex311_36.htm EX-31.1 19170
5 EX-32.1 mrus-ex321_35.htm EX-32.1 9985
  Complete submission text file 0001564590-20-024280.txt   6708853

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mrus-20200331.xsd EX-101.SCH 36510
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrus-20200331_cal.xml EX-101.CAL 47019
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrus-20200331_def.xml EX-101.DEF 89347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20200331_lab.xml EX-101.LAB 265872
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20200331_pre.xml EX-101.PRE 196103
50 EXTRACTED XBRL INSTANCE DOCUMENT mrus-10q_20200331_htm.xml XML 1360156
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 20865521
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences